Navigation Links
Continued Recognition for Excellence; Accelovance Named 2011 "Best CRO"
Date:4/18/2011

ROCKVILLE, Md., April 18, 2011 /PRNewswire-USNewswire/ -- Accelovance, a privately held clinical research company has been named the "Best Contract Research Organization (CRO)" for a third consecutive year. The World Vaccine Congress, held last week at the Gaylord National Hotel and Convention Center, Washington, D.C., hosted its annual Vaccine Industry Excellence (ViE) Awards to honor and generate recognition of the efforts, accomplishments, and positive contributions of companies and individuals in the vaccine industry over the past 12 months.

"Recognition from our colleagues and clients at this level is truly an honor. I believe consistency in performance, value and partnership is what defines our company's success," said Stephen J. Trevisan, President and CEO.

The "Best CRO" category is designed to highlight the importance of contract research services within the vaccine industry; Accelovance has won the award three of the four years it has been a finalist. An international panel of judges evaluates category finalists on quality of work, range of services, strength of client relationships and performance.

"Quality and commitment are what define our organization," remarked Lee Barsky, Vice President of CRO Services. "It is equally rewarding to see how our diverse service offering helps Sponsors maintain growth despite challenging times in the industry."

Accelovance supports the business needs of biotech and small/mid pharma companies with cost-effective, flexible solutions that extend beyond traditional CRO services. Recently, the balanced perspective of study management and site operations positioned Accelovance to successfully rescue two Phase III therapeutic vaccine programs. Additionally, several Phase I vaccine studies in support of novel manufacturing or delivery methods are currently underway.

Headquartered in Rockville, Maryland, Accelovance has developed a unique operational approach for delivering quality, on time,
'/>"/>

SOURCE Accelovance
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Shire plc: Continued Excellent Performance in Q3, Full Year Earnings Expectations Increased, New Value in Pipeline Emerging
2. DSM Biomedical Announces Continued Partnership with Spinelab
3. HSC Trial Shows Continued Significant Hair Growth at One Year Follow-up
4. Continued Demand Makes Monsanto and Agriculture Unique Investment Opportunities, Global Seeds and Traits Lead to Tell Investors
5. China Sky One Medical Confirms Continued Sale of Seven of Eight Products on the Ministry of Healths Warning List
6. GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress
7. Continued Uptake of TNF-Alpha Inhibitors and Interleukin Inhibitors Will Drive $2.2 Billion Growth in the Psoriasis Drug Market
8. Biomatrica Makes Several Key Appointments as Part of Continued Growth Plan
9. New Generation Biofuels Receives NASDAQ Notice of Noncompliance with Continued Listing Requirements
10. Avid Bioservices Expands Executive Team as it Prepares for Continued Growth
11. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Carahsoft and CDS Federal Services have scheduled ... 2pm EST (11am PST), “Natural Language Processing: Converting Raw ... technology can turn raw, heterogeneous data into actionable knowledge ... online webinar will last approximately one hour. , Synopsis: ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... January 14, 2014 In recent years, ... and methods in product development and promotion has led ... This mistrust, fueled by concerns about the insidious impact ... reports of spectacular fines to the world’s biggest pharmas ...
(Date:1/14/2014)... January 13, 2014 Bob Hainsey, a ... than 20 years in the industry, has joined ... Hainsey will serve as the society’s Science and Technology ... join SPIE as our Technology Strategist, further strengthening the ...
Breaking Biology Technology:Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2
... ... , AMSTERDAM, December 8 , ... , Elsevier, a world-leading publisher of scientific, technical ... new SciVal Spotlight tool. The institutions, including,National Chiao Tung University (Taiwan), St. ...
... , ST. JOSEPH, Mich., Dec. 8 ... today that Millipore Corporation has sponsored academic groups from University ... collaborative MetaMiner (Stem Cells) project run by GeneGo. MetaMiner ... pathways and their application in analysis of experimental data as ...
... , , ANNAPOLIS, Md., Dec. ... a biodefense company specializing in the development and commercialization ... today that the Department of Health and Human Services ... request for proposal (RFP) for Recombinant Protective Antigen ...
Cached Biology Technology:SciVal Spotlight Gaining Momentum Across the Globe as More Universities Seek Multidisciplinary View of Research Performance 2SciVal Spotlight Gaining Momentum Across the Globe as More Universities Seek Multidisciplinary View of Research Performance 3Millipore Sponsors Three Academic Memberships for the MetaMiner Stem Cell Project 2Millipore Sponsors Three Academic Memberships for the MetaMiner Stem Cell Project 3BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 2BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 3BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 4
(Date:4/24/2014)... A common plant puts out a welcome mat to bacteria ... mix. , The study published this week in the ... targets during the battle between microbe and host that researchers ... the humble and oft-studied plant Arabidopsis puts out ... It,s as if a hostile army were unknowingly passing by ...
(Date:4/23/2014)... and German . ... the difference between sexes depends on one single element of the ... the two sexual chromosomes are X and Y, whereas women have ... the morphological and physiological differences between males and females. , But ... ago, the X and Y were identical, until the Y started ...
(Date:4/23/2014)... Scarborough research shows that male black widow spiders prefer ... rare example of mate preference by male spiders. ... MacLeod and Maydianne Andrade, a professor in UTSC,s Department ... and the wild that males overwhelmingly chose to mate ... widows can tell whether a potential mate is well-fed ...
Breaking Biology News(10 mins):How a plant beckons the bacteria that will do it harm 2How a plant beckons the bacteria that will do it harm 3Male or female? 2Male or female? 3Picky male black widow spiders prefer well-fed virgins 2
... growth hormone (GH) by healthy elderly people found that the ... but not in body weight or other clinically important outcomes. ... of unhealthy side effects such as soft tissue swelling, joint ... They were also somewhat more likely to develop diabetes. ...
... evidence of the Earth's earliest forest trees, dating back 385 ... after a flash flood in Gilboa, upstate New York, more ... what the entire trees looked like. , Two years ... had fallen sideways, with their trunk, branches, twigs and crown ...
... method of mass-producing disease-fighting antibodies entirely within bacteria has ... of Texas at Austin. , The group led ... to improve upon processes used previously to identify new ... and labor-intensive processes to develop antibodies for treating rheumatoid ...
Cached Biology News:Growth hormone is not the anti-aging bullet for healthy adults 2Growth hormone is not the anti-aging bullet for healthy adults 3Cheaper, better disease treatments expected from faster approach to developing antibodies 2
Tan solid. A glycoside used to permeabilize cellular membranes. Exhibits hemolytic activity. Contaminants: ash: ≤10%. Soluble in H 2 O. pH 4.4 - 4.6. RTECS VQ1400000, CAS 8047-15-2. References:...
...
...
Mouse polyclonal antibody to TNPO2 - transportin 2 (importin 3, karyopherin beta 2b)...
Biology Products: